Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Gastroenterology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/J.GASTRO.2005.10.013PMID 16401475
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension

  2006cited by this paper
• Bosentan therapy for portopulmonary hypertension

  2005cited by this paper
• Exercise testing in pulmonary arterial hypertension and in chronic heart failure

  2004cited by this paper
• Increased Sympathetic Nerve Activity in Pulmonary Artery Hypertension

  2004cited by this paper
• Pulmonary circulation : diseases and their treatment

  2004cited by this paper
• Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension.

  2004cited by this paper
• Pulmonary–Hepatic vascular Disorders (PHD)

  2004cited by this paper
• Diagnosis and differential assessment of pulmonary arterial hypertension.

  2004cited by this paper
• Clinical classification of pulmonary hypertension.

  2004cited by this paper
• Pulmonary-Hepatic vascular Disorders (PHD) R. Rodriguez-Roisin*, M.J. Krowka # , Ph. Herve ´ } , M.B. Fallon z , on behalf of the ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee

  2004cited by this paper
• ATS statement: guidelines for the six-minute walk test.

  2002cited by this paper
• Haemodynamic evaluation of pulmonary hypertension

  2002cited by this paper
• Pulmonary artery pressure-flow relations after prostacyclin in primary pulmonary hypertension.

  2002cited by this paper
• Gas exchange responses to continuous incremental cycle ergometry exercise in primary pulmonary hypertension in humans

  2000cited by this paper
• The beta-adrenoceptor.

  1998cited by this paper
• A Review of Why and How We May Use β-Blockers in Congestive Heart Failure

  1998cited by this paper
• A review of why and how we may use beta-blockers in congestive heart failure.

  1998cited by this paper
• The β -Adrenoceptor

  1998cited by this paper
• Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension

  1996cited by this paper
• Haemodynamic assessment.

  1995cited by this paper
• Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

  1995cited by this paper
• Understanding right and left ventricular systolic function and interactions at rest and with exercise in primary pulmonary hypertension.

  1995cited by this paper
• 7 Haemodynamic assessment

  1995cited by this paper
• Cyclic nucleotide dependent relaxation in vascular smooth muscle.

  1994cited by this paper
• Pharmacologic prevention of variceal bleeding and rebleeding.

  1993cited by this paper
• Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group.

  1991cited by this paper
• Noninvasive assessment of hemodynamic improvement during chronic vasodilator therapy in obliterative pulmonary hypertension.

  1986cited by this paper
• The pressure-flow response of the pulmonary circulation in patients with heart failure and pulmonary vascular disease.

  1985cited by this paper
• Psychophysical bases of perceived exertion.

  1982cited by this paper

• The Management of Portopulmonary Hypertension

  2026cites this paper
• Allgemeine Maßnahmen und Management der PAH in besonderen Situationen

  2025cites this paper
• Beta-Blockers in Pulmonary Arterial Hypertension: Physiology Getting in Biology's Way.

  2025cites this paper
• Drugs targeting novel pathways in pulmonary arterial hypertension

  2025cites this paper
• International Liver Transplantation Society practice guideline update on portopulmonary hypertension

  2025cites this paper
• EASL postgraduate course report: Vascular biology in chronic liver disease and clinical management implications

  2025cites this paper
• Portopulmonary hypertension: diagnosis and preoperative management.

  2025cites this paper
• Atrial Arrhythmias in Patients with Pulmonary Hypertension.

  2024cites this paper
• Die Rolle des Anästhesisten bei Lebertransplantationen – präoperative Evaluation

  2024cites this paper
• Pulmonary Artery Denervation: An Emerging Treatment for Pulmonary Hypertension.

  2024cites this paper
• Effects of β-blockers on the Outcomes in Patients with Pulmonary Arterial Hypertension Stratified by the Presence of Comorbid Conditions: a Multicenter Prospective Cohort Study (BNP-PL).

  2024cites this paper
• Autonomic control of the pulmonary circulation: Implications for pulmonary hypertension

  2024cites this paper
• Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation

  2024cites this paper
• S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)

  2024cites this paper
• Guía de Práctica Clínica Mexicana de Hipertensión Pulmonar

  2024cites this paper
• Cardiac Arrhythmias in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Mechanistic Insights, Pathophysiology, and Outcomes

  2024cites this paper
• Pulmonary Complications of Portal Hypertension.

  2024cites this paper
• Carotid Baroreceptor Stimulation Improves Pulmonary Arterial Remodeling and Right Ventricular Dysfunction in Pulmonary Arterial Hypertension

  2024cites this paper
• Pulmonary complications of advanced chronic liver diseases: an updated review

  2024cites this paper
• Frontiers in Pulmonary Hypertension: A Comprehensive Insight of Etiological Advances.

  2024cites this paper
• "Portopulmonary hypertension: Management and liver transplantation evaluation".

  2023cites this paper
• Pulmonary Assessment of the Liver Transplant Recipient.

  2023cites this paper
• Assessment and Management of Patients with Portopulmonary Hypertension Undergoing Liver Transplantation

  2023cites this paper
• Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association.

  2023cites this paper
• Treatment of pulmonary arterial hypertension: recent progress and a look to the future.

  2023cites this paper
• Portopulmonary Hypertension: An Updated Review

  2023cites this paper
• Cardiac Syndromes in Liver Disease: A Clinical Conundrum

  2023cites this paper
• When Nothing Goes Right: Risk Factors and Biomarkers of Right Heart Failure after Left Ventricular Assist Device Implantation

  2022cites this paper
• Portopulmonary Hypertension: A Review of the Current Literature.

  2022cites this paper
• Novel and emerging therapies in pulmonary arterial hypertension

  2022cites this paper
• Portopulmonary hypertension: Current developments and future perspectives

  2022cites this paper
• Management of Decompensated Cirrhosis and Associated Syndromes.

  2022cites this paper
• Cardiac and Hemodynamic Manifestations of Hereditary Hemorrhagic Telangiectasia.

  2022cites this paper
• Progressive dyspnoea in a patient with idiopathic non-cirrhotic portal hypertension

  2022cites this paper
• Beta-blockers in pulmonary arterial hypertension: Time for a second thought?

  2022cites this paper
• Portopulmonary Hypertension.

  2022cites this paper
• Porto-pulmonary arterial hypertension: Translation of pathophysiological concepts to the bedside.

  2022cites this paper
• Portopulmonary Hypertension: A Review

  2022cites this paper
• Right Ventricular Pathobiology

  2021cites this paper
• Pulmonary Hypertension

  2021cites this paper
• Arrhythmias in Right-Heart Failure due to Pulmonary Hypertension

  2021cites this paper
• Atualização no Tratamento da Hipertensão Arterial Pulmonar

  2021cites this paper
• Management of arrhythmias in pulmonary hypertension

  2021cites this paper
• Pulmonary Vascular Disease as a Systemic and Multisystem Disease.

  2021cites this paper
• Hepatopulmonary Syndrome and Portopulmonary Hypertension: Pulmonary Vascular Complications of Liver Disease.

  2021cites this paper
• [11C]meta-hydroxyephedrine PET evaluation in experimental pulmonary arterial hypertension: Effects of carvedilol of right ventricular sympathetic function

  2021cites this paper
• Keeping Patients with End-Stage Liver Disease Alive While Awaiting Transplant: Management of Complications of Portal Hypertension.

  2021cites this paper
• Complications of Liver Disease

  2021cites this paper
• The Anatolian Journal of Cardiology.

  2020cites this paper
• Right Heart Failure in Pulmonary Hypertension.

  2020cites this paper
• Perioperative Management of Pulmonary Hypertension. a Review

  2020cites this paper
• Pathophysiology Behind Cardiopulmonary Complications of Cirrhosis and Portal Hypertension

  2020cites this paper
• Neurohormonal Modulation as a Therapeutic Target in Pulmonary Hypertension

  2020cites this paper
• Treatment of right ventricular dysfunction and heart failure in pulmonary arterial hypertension.

  2020cites this paper
• Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications

  2020cites this paper
• Manifestaciones extrahepáticas de la cirrosis

  2020cites this paper
• Hepatopulmonary Syndrome and Portopulmonary Hypertension: Current Status and Implications for Liver Transplantation

  2020cites this paper
• Pulmonary manifestations of chronic liver disease: a comprehensive review

  2020cites this paper
• Pharmacology of Pulmonary Arterial Hypertension: An Overview of Current and Emerging Therapies.

  2020cites this paper
• Right Ventricular Function in Chronic Heart Failure: From the Diagnosis to the Therapeutic Approach

  2020cites this paper
• Atrial arrhythmias in chronic lung disease-associated pulmonary hypertension

  2020cites this paper
• Pulmonary Complications in Patients with Liver Cirrhosis

  2020cites this paper
• Liver transplantation and cardiac illness: Current evidences and future directions

  2020cites this paper
• Pulmonary arterial hypertension: the case for a bioelectronic treatment

  2019cites this paper
• Trends in the off‐label use of β‐blockers in pediatric patients

  2019cites this paper
• Pulmonary artery denervation - the time has come for a multicentre blinded randomised controlled trial.

  2019cites this paper
• Pulmonary Complications of Portal Hypertension.

  2019cites this paper
• Cardiac sympathetic dysfunction in pulmonary arterial hypertension: lesson from left-sided heart failure

  2019cites this paper
• Transection of the cervical sympathetic trunk inhibits the progression of pulmonary arterial hypertension via ERK-1/2 Signalling

  2019cites this paper
• Pulmonary Evaluation of Liver Transplant Candidates

  2019cites this paper
• Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease

  2019cites this paper
• Exposome and Diet

  2019cites this paper
• Pathophysiology, incidence, management, and consequences of cardiac arrhythmia in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

  2019cites this paper
• Respiratory Complications in Acute and Chronic Liver Disease

  2018cites this paper
• Neurohormonal modulation as therapeutic avenue for right ventricular dysfunction in pulmonary artery hypertension: till the dawn, waiting.

  2018cites this paper
• Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Summary of Recommendations.

  2018cites this paper
• Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Summary of Recommendations.

  2018cites this paper
• Management of Severe Pulmonary Hypertensive Disease for Surgical and Nonsurgical Procedures.

  2018cites this paper
• Primary and Secondary Pulmonary Hypertension

  2018cites this paper
• Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement

  2018cites this paper
• Pulmonary vascular complications in portal hypertension and liver disease : A concise review

  2018cites this paper
• EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.

  2018cites this paper
• New drugs, therapeutic strategies, and future direction for the treatment of Pulmonary Arterial Hypertension.

  2018cites this paper
• Beta1-adrenoceptor antagonist, metoprolol attenuates cardiac myocyte Ca2+ handling dysfunction in rats with pulmonary artery hypertension

  2018cites this paper
• Morphologic and Functional Changes in Right‐Sided Cardiac Chambers in Patients With Chronic Liver Disease and Normal Pulmonary Artery Pressure

  2018cites this paper
• Right Heart Involvement in Hepatic Diseases

  2018cites this paper
• Effects of Beta Blockers and ACE Inhibitors after Left Ventricular Assist Device Implantation

  2018cites this paper
• [Liver diseases and pulmonary vascular disorders].

  2018cites this paper
• Diagnosis, Treatment, and Management of Orthotopic Liver Transplant Candidates With Portopulmonary Hypertension

  2018cites this paper
• Commentary: Octopamine Drives Endurance Exercise Adaptations in Drosophila

  2018cites this paper
• Hepatic Critical Care

  2018cites this paper
• Endothelial Phenotype Evoked by Low Dose Carvedilol in Pulmonary Hypertension

  2018cites this paper
• Electrical Vagal Nerve Stimulation Ameliorates Pulmonary Vascular Remodeling and Improves Survival in Rats With Severe Pulmonary Arterial Hypertension

  2018cites this paper
• [Portopulmonary hypertension: Updated review].

  2018cites this paper
• Effect of heart rate reduction in pulmonary arterial hypertension.

  2018cites this paper
• Autonomic Nervous System in Pulmonary Arterial Hypertension: Time to Rest and Digest

  2018cites this paper
• Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry.

  2017cites this paper
• Individualizing heart failure core measures and use of beta blockers insevere pulmonary hypertension?a teachable moment

  2017cites this paper
• Portopulmonary Hypertension and Hepatopulmonary Syndrome

  2017cites this paper
• Mechanisms of Effort Intolerance in Patients With Heart Failure and Borderline Ejection Fraction.

  2017cites this paper